CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option

CAR-Based Therapy for Autoimmune Diseases: A Novel Powerful Option

The pervasive application of chimeric antigen receptor (CAR)-based cellular therapies in the treatment of oncological diseases has long been recognized. However, CAR T cells can target and eliminate autoreactive cells in autoimmune and immune-mediated diseases. By doing so, they can contribute to an...

Full description

Bibliographic Details
Main Authors:	Györgyi Műzes, Ferenc Sipos
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	Cells
Subjects:	chimeric antigen receptor CAR T CAR Treg autoimmune immune-mediated CAR-based therapy
Online Access:	https://www.mdpi.com/2073-4409/12/11/1534

Similar Items

CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis
by: Cody D. Moorman, et al.
Published: (2023-10-01)

CAR-engineered T cell therapy as an emerging strategy for treating autoimmune diseases
by: Jovana Vukovic, et al.
Published: (2024-10-01)

CAR-T cell therapy: developments, challenges and expanded applications from cancer to autoimmunity
by: Yaojie Kong, et al.
Published: (2025-01-01)

Expanding the Horizons of CAR-T Cell Therapy: A Review of Therapeutic Targets Across Diverse Diseases
by: Alejandrina Hernández-López, et al.
Published: (2025-01-01)

Approved CAR-T therapies have reproducible efficacy and safety in clinical practice
by: Daniel Goyco Vera, et al.
Published: (2024-12-01)

CAR-T: from bench to bedside
by: M. О. Popova, et al.
Published: (2024-09-01)

Advance in chimeric antigen receptor T therapy in autoimmune diseases
by: Xiaolan Ji, et al.
Published: (2025-03-01)

CAR-T Cells/-NK Cells in Cancer Immunotherapy and the Potential of MSC to Enhance Its Efficacy: A Review
by: Ler Yie Chan, et al.
Published: (2022-03-01)

Application of CAR-T Cell Therapy beyond Oncology: Autoimmune Diseases and Viral Infections
by: Ekaterina Zmievskaya, et al.
Published: (2021-01-01)

CAR-based cell therapy: evaluation with bibliometrics and patent analysis
by: Yajun Yuan, et al.
Published: (2021-11-01)

Alternative CAR Therapies: Recent Approaches in Engineering Chimeric Antigen Receptor Immune Cells to Combat Cancer
by: Carlos Moreno, et al.
Published: (2022-06-01)

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin’s Lymphoma
by: Maria Giraudo, et al.
Published: (2024-03-01)

High specificity of engineered T cells with third generation CAR (CD28-4-1BB-CD3-ζ) based on biotin-bound monomeric streptavidin for potential tumor immunotherapy
by: Jorge Gallego-Valle, et al.
Published: (2024-09-01)

Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review
by: Vahid Moradi, et al.
Published: (2024-06-01)

Acute T-cell lymphoblastic leukemia: chimeric antigen receptor technology may offer a new hope
by: Jiajie Jing, et al.
Published: (2024-08-01)

From spear to trident: Upgrading arsenal of CAR-T cells in the treatment of multiple myeloma
by: Jin Zhao, et al.
Published: (2024-05-01)

Application and Design of Switches Used in CAR
by: Paweł Głowacki, et al.
Published: (2022-06-01)

New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies
by: Yuanyuan Yang, et al.
Published: (2024-11-01)

CAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications
by: Motahareh Arjomandnejad, et al.
Published: (2022-01-01)

Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
by: Ivana Kutle, et al.
Published: (2024-12-01)

Natural Receptor- and Ligand-Based Chimeric Antigen Receptors: Strategies Using Natural Ligands and Receptors for Targeted Cell Killing
by: Gianna M. Branella, et al.
Published: (2021-12-01)

Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
by: Ivana Kutle, et al.
Published: (2025-02-01)

Preclinical specificity & activity of a fully human 41BB-expressing anti-CD19 CART- therapy for treatment-resistant autoimmune disease
by: Binghao J. Peng, et al.
Published: (2024-06-01)

The prognostic utility of 18F-FDG PET parameters in lymphoma patients under CAR-T-cell therapy: a systematic review and meta-analysis
by: Akram Al-Ibraheem, et al.
Published: (2024-09-01)

CAR-Treg cell therapies and their future potential in treating ocular autoimmune conditions
by: Alan R. Abraham, et al.
Published: (2023-04-01)

Editorial: Efficacy and safety of CAR-T cell therapy in hematologic malignancies
by: Marcos de Lima, et al.
Published: (2024-08-01)

Application of novel CAR technologies to improve treatment of autoimmune disease
by: Abigail Cheever, et al.
Published: (2024-10-01)

Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations
by: Swati Garg, et al.
Published: (2023-11-01)

Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01)

Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
by: V. K. Bozhenko, et al.
Published: (2023-04-01)

Charting new paradigms for CAR-T cell therapy beyond current Achilles heels
by: Ying Li, et al.
Published: (2024-05-01)

Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis
by: Lijia Ou, et al.
Published: (2023-12-01)

From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases
by: Yannick Bulliard, et al.
Published: (2024-12-01)

How CAR T Cells Breathe
by: Christopher Forcados, et al.
Published: (2022-04-01)

CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
by: Jialin Lu, et al.
Published: (2024-08-01)

Rapidly-manufactured CD276 CAR-T cells exhibit enhanced persistence and efficacy in pancreatic cancer
by: Tian Deng, et al.
Published: (2024-07-01)

Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy
by: Fatemeh Dehghan, et al.
Published: (2025-02-01)

A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
by: Na Li, et al.
Published: (2024-06-01)

Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy
by: Ross E Staudt, et al.
Published: (2022-12-01)

In silico and in vivo analysis reveal impact of c-Myc tag in FMC63 scFv-CD19 protein interface and CAR-T cell efficacy
by: Ana Julia Ferreira Lima, et al.
Published: (2024-12-01)